Funding for this research was provided by:
Vetenskapsrådet (K2013-52X-20229-08-5)
Sahlgrenska Universitetssjukhuset (ALFGBG-437971)
Research fund at Skaraborg Hospital Skövde
Article History
Received: 26 April 2018
Accepted: 26 September 2018
First Online: 15 October 2018
Compliance with ethical standards
:
: Märit Wallander has has received lecture fees from Amgen and Meda, and consulting fees from Amgen and UCB Pharma. Kristian F Axelsson has received lecture fees from Meda/Mylan, Lilly and Amgen. Dan Lundh has no conflicts of interest. Mattias Lorentzon has received lecture fees from Amgen, Lilly, Meda, Renapharma, UCB Pharma, and consulting fees from Amgen, Radius Health, UCB Pharma, Renapharma and Consilient Health.